Recent advances and challenges of repurposing nanoparticle-based drug delivery systems to enhance cancer immunotherapy

od Lim, Seungho, Park, Jooho, Shim, Man Kyu, Um, Wooram, Yoon, Hong Yeol, Ryu, Ju Hee, Lim, Dong-Kwon, Kim, Kwangmeyung
izdano v Theranostics (2019)

Doxorubicin-Loaded PLGA Nanoparticles for Cancer Therapy: Molecular Weight Effect of PLGA in Doxorubicin Release for Controlling Immunogenic Cell Death

od Choi, Yongwhan, Yoon, Hong Yeol, Kim, Jeongrae, Yang, Suah, Lee, Jaewan, Choi, Ji Woong, Moon, Yujeong, Kim, Jinseong, Lim, Seungho, Shim, Man Kyu, Jeon, Sangmin, Kwon, Ick Chan, Kim, Kwangmeyung
izdano v Pharmaceutics (2020)

Bioorthogonally surface‐edited extracellular vesicles based on metabolic glycoengineering for CD44‐mediated targeting of inflammatory diseases

od Lim, Gyeong Taek, You, Dong Gil, Han, Hwa Seung, Lee, Hansang, Shin, Sol, Oh, Byeong Hoon, Kumar, E. K. Pramod, Um, Wooram, Kim, Chan Ho, Han, Seungsu, Lee, Sangho, Lim, Seungho, Yoon, Hong Yeol, Kim, Kwangmeyung, Kwon, Ick Chan, Jo, Dong‐Gyu, Cho, Yong Woo, Park, Jae Hyung
izdano v J Extracell Vesicles (2021)